{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:43:27Z","timestamp":1762508607971,"version":"3.44.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.compbiomed.2021.104891","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T09:51:18Z","timestamp":1632909078000},"page":"104891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection"],"prefix":"10.1016","volume":"138","author":[{"given":"Utpala Nanda","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1226-7226","authenticated-orcid":false,"given":"Md Omar","family":"Faruqe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md","family":"Mehedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamim","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-1821","authenticated-orcid":false,"given":"M. Babul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-8709","authenticated-orcid":false,"given":"Watshara","family":"Shoombuatong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.M.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-1006","authenticated-orcid":false,"given":"Mohammad Ali","family":"Moni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2021.104891_bib2","article-title":"A novel coronavirus outbreak from Wuhan city in China, rapid need for emergency departments preparedness and response; a letter to editor,","volume":"8","author":"Alavi-Moghaddam","year":"2020","journal-title":"Archives of Academic Emergency Medicine"},{"key":"10.1016\/j.compbiomed.2021.104891_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China,","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2021.104891_bib4","doi-asserted-by":"crossref","first-page":"113661","DOI":"10.1016\/j.eswa.2020.113661","article-title":"A machine learning model to identify early stage symptoms of SARS-cov-2 infected patients,","volume":"160","author":"Ahamad","year":"2020","journal-title":"Expert Syst. Appl."},{"key":"10.1016\/j.compbiomed.2021.104891_bib5","doi-asserted-by":"crossref","first-page":"107126","DOI":"10.1016\/j.knosys.2021.107126","article-title":"Tclustvid: a novel machine learning classification model to investigate topics and sentiment in covid-19 tweets,","volume":"226","author":"Satu","year":"2021","journal-title":"Knowl. Base Syst."},{"key":"10.1016\/j.compbiomed.2021.104891_bib6","doi-asserted-by":"crossref","DOI":"10.2196\/25884","article-title":"Machine learning approach to predicting COVID-19 disease severity based on clinical blood test data: statistical analysis and model development","volume":"9","author":"Aktar","year":"2021","journal-title":"JMIR Medical Informatics"},{"key":"10.1016\/j.compbiomed.2021.104891_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.compbiomed.2021.104891_bib8","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/cncr.33042","article-title":"Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from wuhan, China","volume":"126","author":"Zhang","year":"2020","journal-title":"Cancer"},{"year":"2020","series-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019\u2014COVID-NET, 14 states","author":"Garg","key":"10.1016\/j.compbiomed.2021.104891_bib9"},{"key":"10.1016\/j.compbiomed.2021.104891_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25889","article-title":"The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis","author":"Zhao","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib11","doi-asserted-by":"crossref","first-page":"104668","DOI":"10.1016\/j.compbiomed.2021.104668","article-title":"Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes","volume":"136","author":"Islam","year":"2021","journal-title":"Comput. Biol. Med."},{"author":"Zimmer","key":"10.1016\/j.compbiomed.2021.104891_bib12"},{"key":"10.1016\/j.compbiomed.2021.104891_bib13","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in west africa: a non-specific beneficial effect of BCG?,","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.compbiomed.2021.104891_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.compbiomed.2021.104891_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-bissau: a beneficial effect of BCG vaccination for girls: community based case\u2013control study,","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.compbiomed.2021.104891_bib17","first-page":"185","article-title":"The efficacy of bacillus calmette-guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly,","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.compbiomed.2021.104891_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations, Nihon Ronen Igakkai Zasshi","volume":"42","author":"Ohrui","year":"2005","journal-title":"Jpn. J. Geriatr."},{"key":"10.1016\/j.compbiomed.2021.104891_bib19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.compbiomed.2021.104891_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2020.04.001","article-title":"COVID-19 and bacillus calmette-gu\u00e9rin: what is the link?","author":"Hegarty","year":"2020","journal-title":"European Urology Oncology"},{"key":"10.1016\/j.compbiomed.2021.104891_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/bioinformatics\/18.1.207","article-title":"Genesis: cluster analysis of microarray data","volume":"18","author":"Sturn","year":"2002","journal-title":"Bioinformatics"},{"year":"2020","series-title":"Pathogenetic profiling of COVID-19 and SARS-like viruses, briefings in bioinformatics","author":"Nain","key":"10.1016\/j.compbiomed.2021.104891_bib22"},{"key":"10.1016\/j.compbiomed.2021.104891_bib23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/diagnostics11081383","article-title":"Machine learning approaches to identify patient comorbidities and symptoms that increased risk of mortality in COVID-19","volume":"11","author":"Aktar","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.compbiomed.2021.104891_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/bib\/bbaa376","article-title":"Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease","volume":"22","author":"Moni","year":"2021","journal-title":"Briefings Bioinf."},{"year":"2021","series-title":"Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: a bioinformatics approach, Saudi Journal of Biological Sciences","author":"Auwul","key":"10.1016\/j.compbiomed.2021.104891_bib25"},{"key":"10.1016\/j.compbiomed.2021.104891_bib26","article-title":"Network-based identification genetic effect of SARS-CoV-2 infections to idiopathic pulmonary fibrosis (IPF) patients","author":"Taz","year":"2020","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib27","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/bib\/bbab026","article-title":"Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients","volume":"22","author":"Taz","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab115","article-title":"Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients","author":"Mahmud","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/bib\/bbab003","article-title":"Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases","volume":"22","author":"Satu","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab126","article-title":"Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders","author":"Nashiry","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-01151-3","article-title":"COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disorders","volume":"11","author":"Moni","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.compbiomed.2021.104891_bib32","doi-asserted-by":"crossref","first-page":"106177","DOI":"10.1016\/j.ijantimicag.2020.106177","article-title":"Design of novel viral attachment inhibitors of the spike glycoprotein (s) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics","volume":"56","author":"Oany","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"year":"2015","series-title":"Mycobacterium bovis bacillus calmette-gu\u00e9rin (BCG) reprograms M2 macrophages to promote antitumor t cell responses (TUM6P. 1007)","author":"Lardone","key":"10.1016\/j.compbiomed.2021.104891_bib33"},{"key":"10.1016\/j.compbiomed.2021.104891_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-18528-y","article-title":"Mycobacterium tuberculosis exploits a molecular off switch of the immune system for intracellular survival","volume":"8","author":"von Both","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2021.104891_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.03.021","article-title":"A dynamic immune response shapes COVID-19 progression","author":"Ong","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.compbiomed.2021.104891_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/infdis\/jix327","article-title":"Genetic profiling and comorbidities of zika infection","volume":"216","author":"Moni","year":"2017","journal-title":"J. Infect. Dis."},{"year":"2015","series-title":"Clinical Bioinformatics and Computational Modelling for Disease Comorbidities Diagnosis","author":"Moni","key":"10.1016\/j.compbiomed.2021.104891_bib38"},{"key":"10.1016\/j.compbiomed.2021.104891_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2043-9113-4-8","article-title":"A software for disease comorbidity risk assessment,","volume":"4","author":"Moni","year":"2014","journal-title":"J. Clin. Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fcell.2015.00028","article-title":"How to build personalized multi-omics comorbidity profiles","volume":"3","author":"Moni","year":"2015","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/j.compbiomed.2021.104891_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000807","article-title":"Protein\u2013protein interactions essentials: key concepts to building and analyzing interactome networks","volume":"6","author":"De Las Rivas","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib42","article-title":"The STRING database in 2017: quality-controlled protein\u2013protein association networks, made broadly accessible","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib43","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks,","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"year":"2009","series-title":"Cyto-hubba: a cytoscape plug-in for hub object analysis in network biology, in: 20th International Conference on Genome Informatics","author":"Chen","key":"10.1016\/j.compbiomed.2021.104891_bib44"},{"key":"10.1016\/j.compbiomed.2021.104891_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib46","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.compbiomed.2021.104891_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.compbiomed.2021.104891_bib48","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib49","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants,","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2021.104891_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-15-333","article-title":"Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies","volume":"15","author":"Moni","year":"2014","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.compbiomed.2021.104891_bib51","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis,","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib52","doi-asserted-by":"crossref","first-page":"D260","DOI":"10.1093\/nar\/gkx1126","article-title":"2018: update of the open-access database of transcription factor binding profiles and its web framework","volume":"46","author":"Khan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib53","doi-asserted-by":"crossref","first-page":"D163","DOI":"10.1093\/nar\/gkq1107","article-title":"miRTarBase: a database curates experimentally validated microRNA\u2013target interactions,","volume":"39","author":"Hsu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib54","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update,","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib55","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2021.104891_bib56","doi-asserted-by":"crossref","first-page":"D948","DOI":"10.1093\/nar\/gky868","article-title":"The comparative toxicogenomics database: update 2019,","volume":"47","author":"Davis","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib57","article-title":"\u00c0. Bravo, N. Queralt-Rosinach, A. Guti\u00e9rrez-Sacrist\u00e1n, J. Deu-Pons, E. Centeno, J. Garc\u0131\u0301a-Garc\u0131\u0301a, F. Sanz, L.I. Furlong, DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","author":"Pi\u00f1ero","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib58","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1073\/pnas.90.21.10365","article-title":"Molecular cloning and characterization of the human A3 adenosine receptor","volume":"90","author":"Salvatore","year":"1993","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.compbiomed.2021.104891_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(98)00788-2","article-title":"Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?","volume":"365","author":"Von Lubitz","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-5728(97)00267-1","article-title":"Chemokines and chemotaxis of leukocytes in infectious meningitis","volume":"85","author":"Lahrtz","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib61","first-page":"388","article-title":"Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis","volume":"13","author":"Ahad","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.compbiomed.2021.104891_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2141.2001.02719.x","article-title":"Killer t-cell induction in patients with blastic natural killer cell lymphoma\/leukaemia: implications for successful treatment and possible therapeutic strategies","volume":"113","author":"Yamada","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2004.12.056","article-title":"Association study of the chemokine, CXC motif, ligand 1 (CXCL1) gene with sporadic alzheimer's disease in a Japanese population","volume":"379","author":"Tamura","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.compbiomed.2021.104891_bib64","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1440-1843.2006.00933.x","article-title":"Elevated levels of interferon \u03b3 -inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis","volume":"11","author":"Sugiyama","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.compbiomed.2021.104891_bib65","article-title":"Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.compbiomed.2021.104891_bib66","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1073\/pnas.0609954104","article-title":"A functional SNP of interferon-\u03b3 gene is important for interferon-\u03b1-induced and spontaneous recovery from hepatitis c virus infection,","volume":"104","author":"Huang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.compbiomed.2021.104891_bib67","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1172\/JCI111539","article-title":"Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1\/LFA-1 surface expression in normal and deficient leukocytes","volume":"74","author":"Arnaout","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.compbiomed.2021.104891_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1369-1600.2007.00082.x","article-title":"Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence","volume":"13","author":"Xuei","year":"2008","journal-title":"Addiction Biol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib69","first-page":"797","article-title":"Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by h. Pylori and NSAID","volume":"53","author":"Wu","year":"2006","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.compbiomed.2021.104891_bib70","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.4049\/jimmunol.1202974","article-title":"Impaired TLR5 functionality is associated with survival in melioidosis","volume":"190","author":"West","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib71","doi-asserted-by":"crossref","first-page":"116935","DOI":"10.1016\/j.jns.2020.116935","article-title":"Part II. High-dose methotrexate with leucovorin rescue for severe COVID-19: an immune stabilization strategy for SARS-CoV-2 induced \u2018PANIC\u2019attack","author":"Frohman","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.compbiomed.2021.104891_bib72","first-page":"1033","volume":"vol. 395","author":"Mehta","year":"2020"},{"key":"10.1016\/j.compbiomed.2021.104891_bib73","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.compbiomed.2021.104891_bib74","doi-asserted-by":"crossref","first-page":"110168","DOI":"10.1016\/j.mehy.2020.110168","article-title":"Common determinants of severe covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related siglecs, siglec-3 and siglec-5\/14","volume":"144","author":"Murch","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.compbiomed.2021.104891_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25900","article-title":"High IL-6\/IFN-\u03b3 ratio could be associated with severe disease in COVID-19 patients","author":"Lagunas-Rangel","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib76","doi-asserted-by":"crossref","first-page":"153336","DOI":"10.1016\/j.phymed.2020.153336","article-title":"Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula lian hua qing wen in corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW","volume":"79","author":"Zheng","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.compbiomed.2021.104891_bib77","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1021\/pr400573k","article-title":"Quantitative proteome analysis of alveolar type-II cells reveals a connection of integrin receptor subunits beta 2\/6 and WNT signaling","volume":"12","author":"Mukhametshina","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib78","doi-asserted-by":"crossref","first-page":"110653","DOI":"10.1016\/j.biopha.2020.110653","article-title":"Candesartan could ameliorate the COVID-19 cytokine storm","volume":"131","author":"Elkahloun","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2021.104891_bib79","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.biocel.2006.02.003","article-title":"Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa b and CCAAT\/enhancer binding protein","volume":"38","author":"Yan","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25997","article-title":"Consider TLR5 for new therapeutic development against COVID-19","author":"Chakraborty","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib81","doi-asserted-by":"crossref","first-page":"106044","DOI":"10.1016\/j.ijantimicag.2020.106044","article-title":"Widely available lysosome targeting agents should be considered as a potential therapy for COVID-19","author":"Homolak","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.compbiomed.2021.104891_bib82","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088716","article-title":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","volume":"9","author":"Faure","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.compbiomed.2021.104891_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib","author":"Wu","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.compbiomed.2021.104891_bib85","article-title":"Potential role of IL-17 blocking agents in the treatment of severe COVID-19?","author":"Bulat","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.compbiomed.2021.104891_bib86","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa462","article-title":"Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients","author":"Ouyang","year":"2020","journal-title":"Clin. Infect. Dis."},{"author":"Bcg vaccination to prevent Covid-19-full text view","key":"10.1016\/j.compbiomed.2021.104891_bib87"},{"key":"10.1016\/j.compbiomed.2021.104891_bib88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","article-title":"Identification of natural compounds with antiviral activities against SARS-associated coronavirus","volume":"67","author":"Li","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.compbiomed.2021.104891_bib89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3906\/biy-2005-114","article-title":"Potentials of plant-based substance to inhabit and probable cure for the COVID-19","volume":"44","author":"Jahan","year":"2020","journal-title":"Turkish J. Biol."},{"year":"2020","series-title":"Identification of Potential Biomarkers and Inhibitors for SARS-CoV-2 Infection, medRxiv","author":"Gu","key":"10.1016\/j.compbiomed.2021.104891_bib90"},{"key":"10.1016\/j.compbiomed.2021.104891_bib91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"year":"2021","series-title":"Remdesivir, StatPearls","author":"Aleem","key":"10.1016\/j.compbiomed.2021.104891_bib92"},{"key":"10.1016\/j.compbiomed.2021.104891_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.compbiomed.2021.104891_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-019-0132-8","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discovery"},{"key":"10.1016\/j.compbiomed.2021.104891_bib95","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jac\/dkaa403","article-title":"Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis","volume":"76","author":"Kashour","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.compbiomed.2021.104891_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109891","article-title":"Immunopharmacological management of COVID-19: potential therapeutic role of valproic acid","author":"Unal","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.compbiomed.2021.104891_bib97","article-title":"Predicting potential drug targets and repurposable drugs for covid-19 via a deep generative model for graphs","author":"Ray","year":"2020","journal-title":"arXiv Preprint arXiv:2007.02338"},{"key":"10.1016\/j.compbiomed.2021.104891_bib98","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2018.06.011","article-title":"Cyclophilins and cyclophilin inhibitors in nidovirus replication","volume":"522","author":"de Wilde","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.compbiomed.2021.104891_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.04.153","article-title":"Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern","author":"Rudnicka","year":"2020","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521006855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521006855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T19:37:16Z","timestamp":1757878636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482521006855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":98,"alternative-id":["S0010482521006855"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104891","relation":{},"ISSN":["0010-4825"],"issn-type":[{"type":"print","value":"0010-4825"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104891"}}